Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Starting soon Not applicable

Immediate Effects of Ankle Joint Mobilization on Jump Performance in Healthy University Students

NCT07711379 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2026-07-25
Last updated
2026-07-17

Condition(s) studied

Lower Extremity PerformanceAnkle DorsiflexionHealthy Volunteers

Investigational drug(s) / intervention(s)

Mobilization with Movement (MWM)Sham Mobilization

Mobilization with Movement (MWM): A Mulligan Mobilization with Movement technique will be applied to the talocrural joint. During active weight-bearing lunge movement, a sustained posterior talar glide will be applied by the therapist. The intervention will consist of three sets of ten repetitions.

Sham Mobilization: Participants will perform the same active movement in the same position as the experimental group. The therapist will maintain hand contact without applying a therapeutic posterior talar glide.

Study summary

The purpose of this randomized controlled study is to investigate the immediate effects of ankle joint mobilization on countermovement jump performance and ankle dorsiflexion range of motion in healthy university students. Participants will be randomly assigned to either an ankle joint mobilization group or a sham mobilization group. Countermovement jump performance will be assessed using the My Jump Lab mobile application, and ankle dorsiflexion range of motion will be measured using the weight-bearing lunge test with a digital inclinometer before and immediately after the intervention. The findings of this study are expected to improve the understanding of the acute effects of ankle joint mobilization on functional performance and ankle mobility.

Eligibility

Sex
ALL
Min age
18 Years
Max age
30 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Healthy university students aged 18-30 years. * Willing to participate and provide written informed consent. * No history of lower extremity musculoskeletal injury or surgery within the -previous 6 months. * No neurological or vestibular disorders affecting balance or movement. * No contraindications to manual therapy. Exclusion Criteria: * Current pain in the lower extremity or spine. * History of ankle fracture or surgery. * Acute lower extremity injury within the previous 6 months. * Any systemic, neurological, or rheumatological disease affecting movement. * Participation in another intervention study during the study period. * Inability to complete the assessment procedures.

Primary outcome measure(s)

  • Countermovement Jump Performance — Immediately before the intervention and immediately after the intervention (single session).
    Countermovement jump (CMJ) performance will be assessed using the My Jump Lab mobile application. Participants will perform three maximal countermovement jumps with their hands on their hips, and the highest jump height (cm) will be recorded.

Trial sites (1)

FacilityCityRegionStatus
Muş Alparslan University, Vocational School of Health Services Muş Muş
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07711379 on ClinicalTrials.gov ↗ ← All trials in Turkey